Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014
Göran Rådegran, Barbro Kjellström, Björn Ekmehag, et al.
Scandinavian Cardiovascular Journal (2016) Vol. 50, Iss. 4, pp. 243-250
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4227
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4163
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Marius M. Hoeper, Tilmann Kramer, Zixuan Pan, et al.
European Respiratory Journal (2017) Vol. 50, Iss. 2, pp. 1700740-1700740
Open Access | Times Cited: 596
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
David Kylhammar, Barbro Kjellström, Clara Hjalmarsson, et al.
European Heart Journal (2017) Vol. 39, Iss. 47, pp. 4175-4181
Closed Access | Times Cited: 475
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation (2020) Vol. 39, Iss. 12, pp. 1435-1444
Open Access | Times Cited: 155
Exercise-based rehabilitation programmes for pulmonary hypertension
Norman Morris, F. Kermeen, Arwel W. Jones, et al.
Cochrane library (2023) Vol. 2023, Iss. 3
Open Access | Times Cited: 41
Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure
James Hester, Corey E. Ventetuolo, Tim Lahm
Comprehensive physiology (2019), pp. 125-170
Open Access | Times Cited: 133
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Clara Hjalmarsson, Göran Rådegran, David Kylhammar, et al.
European Respiratory Journal (2018) Vol. 51, Iss. 5, pp. 1702310-1702310
Open Access | Times Cited: 106
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial
Vallerie V. McLaughlin, Jean‐Luc Vachiéry, Ronald J. Oudiz, et al.
The Journal of Heart and Lung Transplantation (2019) Vol. 38, Iss. 12, pp. 1286-1295
Open Access | Times Cited: 91
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
Marius M. Hoeper, Christian Apitz, Ekkehard Grünig, et al.
International Journal of Cardiology (2018) Vol. 272, pp. 37-45
Closed Access | Times Cited: 72
Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
Grzegorz Kopeć, Marcin Kurzyna, Ewa Mroczek, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 173-173
Open Access | Times Cited: 65
Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era
Jason G.E. Zelt, Jordan Sugarman, Jason Weatherald, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 6, pp. 2101552-2101552
Open Access | Times Cited: 52
Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study
Sophia Emmons‐Bell, Catherine O. Johnson, Alexandra S Boon-Dooley, et al.
Pulmonary Circulation (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
Stephan Rosenkranz, Richard N. Channick, Kelly Chin, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 1, pp. 205-214
Open Access | Times Cited: 41
Chronic Thromboembolic Pulmonary Hypertension: An Update
Barbara Ruaro, Elisa Baratella, Gaetano Caforio, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 235-235
Open Access | Times Cited: 30
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
Katleen Swinnen, Rozenn Quarck, Laurent Godinas, et al.
European Respiratory Review (2019) Vol. 28, Iss. 154, pp. 190050-190050
Open Access | Times Cited: 48
Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
Thomas Koudstaal, Karin A. Boomars, Mirjam Kool
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 561-561
Open Access | Times Cited: 48
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
Audrey Muller, Pilar Escribano Subías, Catarina Fernandes, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1103-1119
Open Access | Times Cited: 5
PULMONARY ARTERIAL HYPERTENSION IN LATIN AMERICA. THE AGE AND COMORBIDITY PARADOX
Tomás Pulido, Sofía De la Cruz‐Pérez, Daphne I Valencia, et al.
International Journal of Cardiology Congenital Heart Disease (2025) Vol. 19, pp. 100573-100573
Open Access
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis
Dirk Skowasch, Christine Pausch, Dörte Huscher, et al.
ESC Heart Failure (2025)
Open Access
Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe
Andris Skride, Kristaps Šablinskis, Aivars Lejnieks, et al.
Pulmonary Circulation (2018) Vol. 8, Iss. 3, pp. 1-9
Open Access | Times Cited: 39
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Barbro Kjellström, Anna Sandqvist, Clara Hjalmarsson, et al.
ERJ Open Research (2020) Vol. 6, Iss. 4, pp. 00299-2020
Open Access | Times Cited: 34
Predicting mortality during long-term follow-up in pulmonary arterial hypertension
David Kylhammar, Clara Hjalmarsson, Roger Hesselstrand, et al.
ERJ Open Research (2021) Vol. 7, Iss. 2, pp. 00837-2020
Open Access | Times Cited: 32
Plasma markers in pulmonary hypertension subgroups correlate with patient survival
Thomas Koudstaal, Denise van Uden, Jennifer A. C. van Hulst, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)
Grzegorz Kopeć, Olga Dzikowska­‐Diduch, Ewa Mroczek, et al.
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top